eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
2/2017
vol. 3
 
Share:
Send email
Share:
abstract:
Review paper

Recommendations for the treatment of hepatitis B in 2017

Robert Flisiak
,
Waldemar Halota
,
Jerzy Jaroszewicz
,
Jacek Juszczyk
,
Piotr Małkowski
,
Małgorzata Pawłowska
,
Anna Piekarska
,
Krzysztof Simon
,
Krzysztof Tomasiewicz
,
Marta Wawrzynowicz-Syczewska

Clin Exp HEPATOL 2017; 3, 2: 35–46
DOI: https://doi.org/10.5114/ceh.2017.67626
Online publish date: 2017/05/10
View full text Get citation
 
PlumX metrics:
The therapeutic goal which is currently unfrequent but realistic in HBV infected patients is sustained HBsAg clearance. It is preceded by the loss or significant suppression of HBV replication and leads to inhibition of the progression of liver fibrosis, normalization of biochemical indicators of liver damage, reduction in the risk of hepatocellular carcinoma, prolongation of survival, prevention of HBV infection in the transplanted organ in post-transplant patients, enhancement of the quality of life, inhibition or reversal of extrahepatic changes associated with HBV infection, and halting of the spread of HBV infections. Recommendations of Polish Group of Experts for HBV for 2017 provide guidelines to assess treatment eligibility, choice of the first-line drug, monitoring and duration of treatment, management of treatment failure as well as therapy of HBV associated cirrhosis or hepatocellular carcinoma. Moreover it contains advice for treatment of HBV infection in children, females planning pregnancy or pregnant. We also included recommendations for pre- and post-exposure prophylaxis, prevention of HBV transmission from mother to infant, after liver transplantation, on immunosuppressive therapy and during HCV treatment.
keywords:

liver, HBV, therapy
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.